PHH Overview

Share Offering: Park Ha Biological Technology has filed to sell 11.43 million ordinary shares and 11.43 million warrants.

Market Concerns: The filing comes amid concerns over pump-and-dump scams related to penny stock selloffs.

Investigation Announcement: Morris Kandinov LLP is investigating claims from victims of pump-and-dump schemes involving several companies, including Park Ha Biological Technology Co., Ltd. and others, where scammers posed as financial advisors on social media.

Legal Representation Offer: The law firm offers contingency-based representation for affected stockholders, meaning they do not pay fees unless a recovery is made, and encourages victims to reach out for legal assistance.

U.S. Stock Market Performance: U.S. stocks rose this morning with the Dow Jones gaining over 200 points, while the NASDAQ and S&P 500 also saw increases. Communication services shares jumped by 1.6%, although energy stocks dipped by 0.6%.

Notable Stock Movements: Calidi Biotherapeutics and SU Group Holdings experienced significant stock surges of 242% and 203% respectively due to positive developments, while Park Ha Biological Technology and RxSight saw substantial declines of 53% and 40% following negative news.

Stock Market Overview: U.S. stocks showed mixed results, with the Nasdaq Composite dropping over 1% on Monday, while several companies like Mr. Cooper Group and Corcept Therapeutics saw significant gains due to acquisition announcements and successful trial results.

Notable Stock Movements: Mr. Cooper Group shares surged 16.3% following a $9.4 billion acquisition deal, while Corcept Therapeutics experienced an 84.7% increase after meeting trial endpoints; other notable gainers included Southern States Bancshares and Cryoport, among others.